How many employees does Incyte Corporation have?

Incyte Corporation reported 2,844 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 10, 2026. That is up 8.7% from a year earlier.

What is Incyte Corporation's revenue per employee?

Incyte Corporation brought in $5.14B of revenue in fiscal Dec 2025, which is $1.81M per employee. That ranks 6 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Incyte Corporation employees and revenue per employee

INCY · Biotechnology · $23.4B market cap

Incyte Corporation had 2,844 employees at the end of fiscal Dec 2025, up 8.7% from a year earlier. Revenue for the year was $5.14B, up 21.2% from a year earlier, or $1.81M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

2,844

+8.7% YoY

Revenue

$5.14B

+21.2% YoY

Revenue / employee

$1.81M

Peer median $602K

Rank in industry

6 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

INCY employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	2,844	$5.14B	$1.81M	+8.7%	+21.2%
Dec 2024	2,617	$4.24B	$1.62M	+3.7%	+14.8%
Dec 2023	2,524	$3.70B	$1.46M	+8.6%	+8.9%
Dec 2022	2,324	$3.39B	$1.46M	+11.0%	+13.7%
Dec 2021	2,094	$2.99B	$1.43M	+18.1%	+12.0%
Dec 2020	1,773	$2.67B	$1.50M	+21.8%	+23.5%
Dec 2019	1,456	$2.16B	$1.48M	+6.5%	+14.7%
Dec 2018	1,367	$1.88B	$1.38M	+13.2%	+22.5%
Dec 2017	1,208	$1.54B	$1.27M	+23.3%	+38.9%
Dec 2016	980	$1.11B	$1.13M	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Incyte Corporation against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
UTHR United Therapeutics Corporation	1,400	$3.18B	$2.27M	Efficient growth
EXEL Exelixis, Inc.	1,077	$2.32B	$2.15M	Leaner
VRTX Vertex Pharmaceuticals Incorporated	6,400	$12.1B	$1.89M	Efficient growth
INCY Incyte Corporation	2,844	$5.14B	$1.81M	Efficient growth
ALNY Alnylam Pharmaceuticals, Inc.	2,500	$3.71B	$1.49M	Efficient growth
NBIX Neurocrine Biosciences, Inc.	2,000	$2.86B	$1.43M	Efficient growth
BMRN BioMarin Pharmaceutical Inc.	3,221	$3.22B	$1.00M	Efficient growth
MRNA Moderna, Inc.	4,700	$1.94B	$414K	Contracting
FTRE Fortrea Holdings Inc.	14,300	$2.72B	$190K	Leaner

Every Healthcare company

Questions about Incyte Corporation

How many employees does Incyte Corporation have?: Incyte Corporation reported 2,844 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 10, 2026. That is up 8.7% from a year earlier.
What is Incyte Corporation's revenue per employee?: Incyte Corporation brought in $5.14B of revenue in fiscal Dec 2025, which is $1.81M per employee. That ranks 6 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare INCY with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Incyte Corporation's annual reports (Form 10-K), latest filed February 10, 2026. This is data, not a recommendation to buy or sell INCY.